Abstract

Creatine is important for energy metabolism, yet excitable cells such as cardiomyocytes do not synthesize creatine and rely on uptake via a specific membrane creatine transporter (CrT; SLC6A8). This process is tightly controlled with downregulation of CrT upon continued exposure to high creatine via mechanisms that are poorly understood. Our aim was to identify candidate endogenous CrT inhibitors. In 3T3 cells overexpressing the CrT, creatine uptake plateaued at 3 h in response to 5 mM creatine but peaked 33% higher (P < 0.01) in the presence of cycloheximide, suggesting CrT regulation depends on new protein synthesis. Global gene expression analysis identified thioredoxin-interacting protein (Txnip) as the only significantly upregulated gene (by 46%) under these conditions (P = 0.036), subsequently verified independently at mRNA and protein levels. There was no change in Txnip expression with exposure to 5 mM taurine, confirming a specific response to creatine rather than osmotic stress. Small-interfering RNA against Txnip prevented Txnip upregulation in response to high creatine, maintained normal levels of creatine uptake, and prevented downregulation of CrT mRNA. These findings were relevant to the in vivo heart since creatine-deficient mice showed 39.71% lower levels of Txnip mRNA, whereas mice overexpressing the CrT had 57.6% higher Txnip mRNA levels and 28.7% higher protein expression compared with wild types (mean myocardial creatine concentration 124 and 74 nmol/mg protein, respectively). In conclusion, we have identified Txnip as a novel negative regulator of creatine levels in vitro and in vivo, responsible for mediating substrate feedback inhibition and a potential target for modulating creatine homeostasis.

Highlights

  • CREATINE (Cr) entry into cells occurs via the 12 transmembrane domain creatine transporter (CrT; SLC6A8), a family member of the NaϩClϪ-dependent neurotransmitter transporters [16, 34, 37]

  • These findings are reflected in total intracellular creatine levels ([Cr]i), with 3 h exposure to 250 ␮M Cr resulting in a 31% increase in [Cr]i over untreated

  • This study confirmed that exposure of cells to millimolar levels of Cr results in reduced Cr uptake and that this is dependent on the synthesis of new protein [8, 19]

Read more

Summary

Introduction

CREATINE (Cr) entry into cells occurs via the 12 transmembrane domain creatine transporter (CrT; SLC6A8), a family member of the NaϩClϪ-dependent neurotransmitter transporters [16, 34, 37]. Feeding rats excess dietary Cr reduces Cr uptake capacity in the heart while giving ␤-guanidinopropionic acid to deplete intracellular Cr results in increased uptake capacity [5], an effect observed in human muscle cells and G8 myoblasts [19]. One important clue is that exposure of rat and human muscle cells to saturating (mM) levels of Cr results in decreased CrT activity, but that this can be blocked by incubation with cycloheximide (CHX), a widely used protein synthesis inhibitor [19]. This infers synthesis of new protein(s) in response to high Cr, which effectively act to inhibit CrT activity [19]

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.